Since the Johnson & Johnson's shot has come out 4 people who have received it have suffered from low platelet levels and clotting. This clotting so far has taken place within the brain or abdomen of these patients and has lead to one death. European Medicines Agency (EMA) has been the leading drug regulator on this case and has not made any claims that both the vaccine and clotting are correlated to one another. A change in possible protocols of where the vaccine is allowed to be released and what is labeled on the vaccine bottle is being processed for change because of these potential risk factors. Also, as the EMA has been keeping tabs on the AstraZeneca vaccine they have recorded 5 cases of individuals who have suffered from capillary leak syndrome; blood leaking from blood vessels into muscles and body cavities. Countries throughout Europe have considered this information and have chosen to only allow their citizens access to certain vaccines in order to help protect them from the possible side effects. Although this is something important for others to take into consideration throughout the world. The U.S is the leading consumer of the J & J vaccine, should there be more freedom to access other brands of the vaccine?
https://www.theguardian.com/world/2021/apr/09/eu-agency-examines-reports-of-blood-clots-with-jj-covid-vaccine
No comments:
Post a Comment